Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: Concurrent expression in cancer cells from primary tumour and metastatic lymph node

Lung Cancer

Volumn 58, Issue 2, 2007, Pages 205-213

  Saintigny, Pierre ^a,b   Kambouchner, Marianne ^b   Ly, Madani ^c   Gomes, Noëlia ^a   Sainte Catherine, Odile ^a   Vassy, Roger ^b   Czernichow, Sébastien ^b   Letoumelin, Philippe ^b   Breau, Jean Luc ^b   Bernaudin, Jean François ^c   Kraemer, Michel ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b AVICENNE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Cell proliferation; Lymph node; Non small cell lung carcinoma; Vascular endothelial growth factor receptor 3; Vascular endothelial growth factor C

Indexed keywords

KI 67 ANTIGEN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL PROLIFERATION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 34848908049     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.06.021     Document Type: Article

References (36)

1. Ginsberg R.J., Vokes E.E., and Raben A. Non-small-cell lung cancer. In: DeVita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer: principles and practice of oncology. 5th ed. (1997), Lippincott-Raven Publishers, Philadelphia, PA 858-911
2. Brundage M.D., Davies D., and Mackillop W.J. Prognostic factors in non-small-cell lung cancer. Chest 122 (2002) 1037-1057
3. Nathanson S.D. Insights into the mechanisms of lymph node metastases. Cancer 98 (2003) 413-423
4. Cao Y. Emerging mechanisms of tumor lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 5 (2005) 1-9
5. Stacker S.A., Achen M.G., Jussila L., Baldwin M.E., and Alitalo K. Lymphangiogenesis and cancer metastases. Nat Rev Cancer 2 (2002) 573-583
6. Wong S.Y., Haack H., Crowley D., Barry M., Bronson R.T., and Hynes R.O. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res 65 (2005) 9789-9798
7. Achen M.G., and Stacker S.A. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer 119 (2006) 1755-1760
8. Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L.F., and Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201 (2005) 1089-1099
9. Hirakawa S., Brown L.F., Kodama S., Paavonen K., Alitalo K., and Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109 (2007) 1010-1017
10. Ishii H., Yazawa T., Sato H., Suzuki T., Ikeda M., Hayashi Y., et al. Enhancement of pleural dissemination and lymph node metastases of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Lung Cancer 45 (2004) 325-337
11. Jenny B., Harrison J.A., Baetens D., Tille J.C., Burkhardt K., Mottaz H., et al. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas. J Pathol 209 (2006) 34-43
12. Witte D., Thomas A., Ali N., Carlson N., and Younes M. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Anticancer Res 22 (2002) 1463-1466
13. Li R., Younes M., Wheeler T.M., Scardino P., Ohori M., Frolov A., et al. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate. Prostate 58 (2004) 193-199
14. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7 (2001) 192-198
15. Karpanen T., Egeblad M., Karkkainen M.J., Kubo H., Ylä-Herttuala S., Jäättelä M., et al. Vascular endothelial growth factor-C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61 (2001) 1786-1790
16. Skobe M., Hamberg L.M., Hawighorst T., Schirner M., Wolf G.L., Alitalo K., et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 159 (2001) 893-903
17. Chen F., Takenaka K., Ogawa E., Yanagihara K., Otake Y., Wada H., et al. Flt-4-positive endothelial cell density and its clinical significance in non-small-cell lung cancer. Clin Cancer Res 10 (2004) 8548-8553
18. Ogawa E., Takenaka K., Yanagihara K., Kurozumi M., Manabe T., Wada H., et al. Clinical significance of VEGF-C status in tumor cells and stromal macrophages in non-small-cell lung cancer patients. Br J Cancer 91 (2004) 498-503
19. Li Q., Dong X., Gu W., Qiu X., and Wang E. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small-cell lung cancer. Chin Med J (Engl) 116 (2003) 727-730
20. Arinaga M., Noguchi T., Takeno S., Chujo M., Miura T., and Uchida Y. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in patients with non-small-cell lung carcinoma. Cancer 97 (2003) 457-464
21. Kojima H., Shijubo N., Yamada G., Ichimiya S., Abe S., Satoh M., et al. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in patients with T1 lung adenocarcinoma. Cancer 104 (2005) 1668-1677
22. Su J.L., Yang P.C., Shih J.Y., Yang C.Y., Wei L.H., Hsieh C.Y., et al. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9 (2006) 209-223
23. He Y., Rajantie I., Pajusola K., Jeltsch M., Holopainen T., Yla-Herttuala S., et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65 (2005) 4739-4746
24. Achen M.G., Williams R.A., Baldwin M.E., Lai P., Roufail S., Alitalo K., et al. The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer. Growth Factors 20 (2002) 99-107
25. Takizawa H., Kondo K., Fujino H., Kenzaki K., Miyoshi T., Sakiyama S., et al. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small-cell lung cancer. Br J Cancer 95 (2006) 75-79
26. Thiele W., and Sleeman J.P. Tumor-induced lymphangiogenesis: a target for cancer therapy?. J Biotechnol 124 (2006) 224-241
27. Laakkonen P., Waltari M., Holopainen T., Takahashi T., Pytowski B., Steiner P., et al. Vascular endothelial growth factor receptor-3 is involved in tumor angiogenesis and growth. Cancer Res 67 (2007) 593-599
28. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7 (2001) 186-191
29. Masood R., Kundra A., Zhu S., Xia G., Scalia P., Smith D.L., et al. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int J Cancer 104 (2003) 603-610
30. Dias S., Choy M., Alitalo K., and Rafii S. Vascular endothelial growth factor (VEGF)-C signalling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 99 (2002) 2179-2184
31. Su J.L., Yen C.J., Chen P.S., Chuang S.E., Hong C.C., Kuo I.H., et al. The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96 (2007) 541-545
32. Renyi-Vamos F., Tovari J., Fillinger J., Timar J., Paku S., Kenessey I., et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small-cell lung cancer. Clin Cancer Res 11 (2005) 7344-7353
33. Kajita T., Ohta Y., Kimura K., Tamura M., Tanaka Y., Tsunezuka Y., et al. The expression of vascular endothelial growth factor-C and its receptors in non-small cell lung cancer. Br J Cancer 85 (2001) 255-260
34. He Y., Kozaki K., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., et al. Suppression of tumor lymphangiogenesis and lymph node metastases by blocking vascular endothelial growth factor receptor-3 signalling. J Natl Cancer Inst 94 (2002) 819-825
35. Lin J., Lalani A.S., Harding T.C., Gonzalez M., Wu W.W., Luan B., et al. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res 65 (2005) 6901-6909
36. Roberts N., Kloos B., Cassella M., Podgrabinska S., Persaud K., Wu Y., et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 66 (2006) 2650-2657